We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

65 hedge funds and large institutions have $24.6M invested in ENZON PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $23.4M → $24.6M (+$1.25M)

3% less funds holding

Funds holding: 67 → 65 (-2)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

67% less call options, than puts

Call options by funds: $7K | Put options by funds: $21K

Holders
65
Holders Change
-2
Holders Change %
-2.99%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
25
Closed
12
Calls
$7K
Puts
$21K
Net Calls
-$14K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CSC
Cove Street Capital
California
+$879K
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$653K
3
Renaissance Technologies
Renaissance Technologies
New York
+$562K
4
NFA
Nationwide Fund Advisors
Ohio
+$343K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$292K

Top Sellers

Rank Fund Capital Flow
1
MFP
Michael F. Price
-$504K
2
Northern Trust
Northern Trust
Illinois
-$362K
3
PAMU
Pictet Asset Management (UK)
United Kingdom
-$329K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$314K
5
Bank of America
Bank of America
North Carolina
-$226K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
51
Monarch Capital Management
Indiana
$11K +$12.3K +10,000 New
Federated Hermes
52
Federated Hermes
Pennsylvania
$10K +$11.2K +9,098 New
Wells Fargo
53
Wells Fargo
California
$1K -$2.33K -1,891 -65%
KTC
54
Kistler-Tiffany Companies
Pennsylvania
$1K – – –
NFG
55
Next Financial Group
Texas
$1K – – –
WT
56
Whittier Trust
California
$1K – – –
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$38 -$368 -298 -89%
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 +$1.5K +1,215 +69%
PAMU
59
Pictet Asset Management (UK)
United Kingdom
– -$329K -316,200 Closed
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
– -$314K -302,273 Closed
Bank of America
61
Bank of America
North Carolina
– -$226K -182,724 -100%
PP
62
Paloma Partners
Connecticut
– -$168K -161,481 Closed
COPPSERS
63
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$111K -106,947 Closed
Barclays
64
Barclays
United Kingdom
– -$95.1K -77,022 -100%
Deutsche Bank
65
Deutsche Bank
Germany
– -$88.4K -71,574 -99%
SFM
66
Soros Fund Management
New York
– -$52K -50,123 Closed
Nomura Holdings
67
Nomura Holdings
Japan
– -$32K -30,492 Closed
FA
68
FCG Advisors
New Jersey
– -$21K -20,000 Closed
GC
69
Guggenheim Capital
Illinois
– -$16K -15,794 Closed
YCM
70
Yakira Capital Management
Connecticut
– -$6K -5,981 Closed
Bank of Montreal
71
Bank of Montreal
Ontario, Canada
– -$1K -910 Closed
TA
72
Teachers Advisors
New York
– -$1K -551 Closed
Citigroup
73
Citigroup
New York
– +$412 +334 New
1 2
3

ENZN Hedge Fund Activity: Q3 2014 in Review

65 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q3 2014, worth a combined $24.6M — up 5.3% from $23.4M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ENZN and 10 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Cove Street Capital, opening a new position worth an estimated $879K. The largest seller was Michael F. Price, cutting an estimated $504K.

  • 65 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q3 2014, down from 67 in Q2 2014.
  • Funds reported $24.6M of ENZON PHARMACEUTICALS INC stock for Q3 2014, up 5.3% quarter-over-quarter.
  • 10 funds opened new ENZON PHARMACEUTICALS INC positions in Q3 2014 and 12 closed out, a net change of -2 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q3 2014 was Cove Street Capital, an estimated $879K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q3 2014 was Michael F. Price, an estimated $504K sold.

Based on aggregated 13F filings for Q3 2014.